XML 73 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles - Restricted Cash and Restricted Investments (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds   $ 88,662    
Current restricted cash $ 14,492 75,685    
Total current restricted cash and restricted investments 14,492 75,685    
Non-current restricted cash 12,466 12,977    
Total non-current restricted cash and restricted investments 12,466 12,977    
Cash and cash equivalents 188,200 266,280    
Restricted cash and restricted investments 26,958 88,662    
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows [1] 215,158 354,942 $ 361,581 $ 128,531
Collateral for letters of credit for facility leases        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 2,269 3,769    
Collateral with financial institutions        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 10,912 11,662    
Claims processing services        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 13,777 73,226    
Other        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds $ 0 $ 5    
[1] As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the years ended December 31, 2021 and 2020. See Note 5.